Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy

被引：0
|
作者：
Grant, Ellen C. G.
机构：
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2017年 / 217卷 / 02期
关键词：
D O I：
10.1016/j.ajog.2017.05.005
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：232 / 233
页数：3
相关论文
共 50 条
  • [1] Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy REPLY
    Iversen, Lisa
    Hannaford, Philip C.
    Fielding, Shona
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (02) : 233 - 233
  • [2] Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk
    Schildkraut, JM
    Calingaert, B
    Marchbanks, PA
    Moorman, PG
    Rodriguez, GC
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (01): : 32 - 38
  • [3] Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk
    Maxwell, G. L.
    Schildkraut, J. M.
    Calingaert, B.
    Risinger, J. I.
    Dainty, L.
    Marchbanks, P. A.
    Berchuck, A.
    Barrett, J. C.
    Rodriguez, G. C.
    GYNECOLOGIC ONCOLOGY, 2006, 103 (02) : 535 - 540
  • [4] Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives
    Ness, RB
    Grisso, JA
    Klapper, J
    Schlesselman, JJ
    Silberzweig, S
    Vergona, R
    Morgan, M
    Wheeler, JE
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (03) : 233 - 241
  • [5] Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma risk
    Lurie, Galina
    Thompson, Pamela
    McDuffie, Katharine E.
    Carney, Michael E.
    Terada, Keith Y.
    Goodman, Marc T.
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (03): : 597 - 607
  • [6] Combination estrogen-progestin oral contraceptives
    Petitti, DB
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (15): : 1443 - 1450
  • [7] Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer
    Fernandez, E
    LaVecchia, C
    DAvanzo, B
    Franceschi, S
    Negri, E
    Parazzini, F
    BRITISH JOURNAL OF CANCER, 1996, 73 (11) : 1431 - 1435
  • [8] Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
    Ross, RK
    Paganini-Hill, A
    Wan, PC
    Pike, MC
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (04): : 328 - 332
  • [9] Combined estrogen-progestin oral contraceptives - Reply
    Petitti, DB
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (03): : 307 - 308
  • [10] Oral contraceptives, hormone therapy and cardiovascular risk
    Shapiro, S.
    CLIMACTERIC, 2008, 11 (05) : 355 - 363
12345